SARS-CoV-话题@MedSci

#SARS-CoV#

221篇内容 | 1521人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=BioScience Trends：杨文明教授团队发现疏风解毒胶囊对SARS-CoV-2奥密克戎感染轻度患者有效, objectType=article, longId=732304, objectId=edf3e3230414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edf3e3230414, replyNumber=0, likeNumber=46, createdTime=2023-03-03, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edf3e3230414, moduleTitle=BioScience Trends：杨文明教授团队发现疏风解毒胶囊对SARS-CoV-2奥密克戎感染轻度患者有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edf3e3230414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938108, encodeId=e1cd193810821, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=ARD：在巴西大量自身免疫性风湿病患者中接种第三剂同源灭活SARS-CoV-2疫苗后免疫原性增加, objectType=article, longId=731834, objectId=6e88e318344a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e88e318344a, replyNumber=0, likeNumber=50, createdTime=2022-08-09, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e88e318344a, moduleTitle=ARD：在巴西大量自身免疫性风湿病患者中接种第三剂同源灭活SARS-CoV-2疫苗后免疫原性增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e88e318344a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938105, encodeId=a7b5193810517, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Geroscience：SARS-CoV-2的持续病毒RNA脱落与住院COVID-19患者的谵妄发生率和6个月死亡率相关, objectType=article, longId=727108, objectId=4ee0e27108ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee0e27108ff, replyNumber=0, likeNumber=53, createdTime=2023-01-09, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee0e27108ff, moduleTitle=Geroscience：SARS-CoV-2的持续病毒RNA脱落与住院COVID-19患者的谵妄发生率和6个月死亡率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee0e27108ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938098, encodeId=2f701938098da, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JAMA:妊娠期接种SARS-CoV-2 疫苗安全无虞, objectType=article, longId=302006, objectId=76f930200645, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76f930200645, replyNumber=0, likeNumber=49, createdTime=2022-08-03, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76f930200645, moduleTitle=JAMA:妊娠期接种SARS-CoV-2 疫苗安全无虞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76f930200645)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938097, encodeId=090d193809e6b, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=ARD：已患有风湿病和肌肉骨骼疾病的儿童和青少年感染 SARS-CoV-2 的结果, objectType=article, longId=301852, objectId=7daf301852bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7daf301852bb, replyNumber=0, likeNumber=34, createdTime=2022-12-30, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7daf301852bb, moduleTitle=ARD：已患有风湿病和肌肉骨骼疾病的儿童和青少年感染 SARS-CoV-2 的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7daf301852bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938099, encodeId=750519380992e, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Lancet Rheumatology：自身免疫性风湿病患者的混合免疫（感染+疫苗）与疫苗诱导的针对SARS-CoV-2 的免疫比较, objectType=article, longId=723786, objectId=e8a8e237862b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8a8e237862b, replyNumber=0, likeNumber=39, createdTime=2022-12-30, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8a8e237862b, moduleTitle=Lancet Rheumatology：自身免疫性风湿病患者的混合免疫（感染+疫苗）与疫苗诱导的针对SARS-CoV-2 的免疫比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8a8e237862b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938093, encodeId=6ac1193809391, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JNNP:与SARS-CoV-2感染相关的急性缺血性中风研究, objectType=article, longId=300485, objectId=1d543004859d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d543004859d, replyNumber=0, likeNumber=48, createdTime=2022-09-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d543004859d, moduleTitle=JNNP:与SARS-CoV-2感染相关的急性缺血性中风研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d543004859d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938092, encodeId=c93b1938092ef, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nat Commun：中和先前非 Omicron 感染的 Omicron SARS-CoV-2, objectType=article, longId=300854, objectId=434e300854aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434e300854aa, replyNumber=0, likeNumber=52, createdTime=2022-06-06, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434e300854aa, moduleTitle=Nat Commun：中和先前非 Omicron 感染的 Omicron SARS-CoV-2, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=434e300854aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938072, encodeId=896919380e260, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=MOL THER| 妙！科学家发现咀嚼含有ACE2蛋白的口香糖或减少SARS-CoV-2传播, objectType=article, longId=294400, objectId=c64029440082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c64029440082, replyNumber=0, likeNumber=36, createdTime=2022-08-08, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c64029440082, moduleTitle=MOL THER| 妙！科学家发现咀嚼含有ACE2蛋白的口香糖或减少SARS-CoV-2传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c64029440082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938090, encodeId=e10d1938090aa, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=J Hematol Oncol：癌症患者接种SARS-COV2疫苗后的血清学反应, objectType=article, longId=299887, objectId=481729988e87, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=481729988e87, replyNumber=0, likeNumber=45, createdTime=2022-11-20, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=481729988e87, moduleTitle=J Hematol Oncol：癌症患者接种SARS-COV2疫苗后的血清学反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=481729988e87)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938094, encodeId=c49f193809427, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=MMWR：在B.1.617.2(Delta)和B.1.1.529(Omicron)变异优势时期住院的经实验室确认的SARS-CoV-2感染成人的临床特征和转归, objectType=article, longId=300848, objectId=067b30084807, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=067b30084807, replyNumber=0, likeNumber=50, createdTime=2022-07-12, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=067b30084807, moduleTitle=MMWR：在B.1.617.2(Delta)和B.1.1.529(Omicron)变异优势时期住院的经实验室确认的SARS-CoV-2感染成人的临床特征和转归, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=067b30084807)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938066, encodeId=60191938066e5, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=AJH：接受鲁索替尼治疗的骨髓增殖性肿瘤患者对首次 SARS-CoV-2 疫苗接种的反应受损, objectType=article, longId=293129, objectId=4f8329312916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8329312916, replyNumber=0, likeNumber=51, createdTime=2022-09-19, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8329312916, moduleTitle=AJH：接受鲁索替尼治疗的骨髓增殖性肿瘤患者对首次 SARS-CoV-2 疫苗接种的反应受损, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8329312916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938071, encodeId=aeb119380e15e, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nat Med：孕妇COVID-19疫苗接种与SARS-CoV-2感染, objectType=article, longId=293981, objectId=31ae29398138, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31ae29398138, replyNumber=0, likeNumber=57, createdTime=2022-09-28, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31ae29398138, moduleTitle=Nat Med：孕妇COVID-19疫苗接种与SARS-CoV-2感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31ae29398138)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938103, encodeId=23a2193810317, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Crit Care：SARS-CoV-2相关性中重度低氧性呼吸衰竭患者早期长时间俯卧位是否能改善无创呼吸机治疗的临床结果, objectType=article, longId=726677, objectId=0dd2e26677ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dd2e26677ba, replyNumber=0, likeNumber=35, createdTime=2022-11-09, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dd2e26677ba, moduleTitle=Crit Care：SARS-CoV-2相关性中重度低氧性呼吸衰竭患者早期长时间俯卧位是否能改善无创呼吸机治疗的临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dd2e26677ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938112, encodeId=90291938112f3, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Bioorg Med Chem：羟氯喹抗SARS-CoV-2病毒，再现曙光！, objectType=article, longId=736171, objectId=f08fe3617154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f08fe3617154, replyNumber=0, likeNumber=52, createdTime=2022-11-28, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f08fe3617154, moduleTitle=Bioorg Med Chem：羟氯喹抗SARS-CoV-2病毒，再现曙光！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f08fe3617154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938110, encodeId=e86c1938110f2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JNNP:在接受芬戈莫德治疗的多发性硬化症患者中，SARS-CoV-2 mRNA疫苗接种未能引发体液和细胞免疫反应, objectType=article, longId=734385, objectId=84d8e34385a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d8e34385a7, replyNumber=0, likeNumber=45, createdTime=2023-05-26, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d8e34385a7, moduleTitle=JNNP:在接受芬戈莫德治疗的多发性硬化症患者中，SARS-CoV-2 mRNA疫苗接种未能引发体液和细胞免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84d8e34385a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938076, encodeId=62e619380e6e0, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JEADV：89岁患者接种SARS-CoV-19BNT162b2疫苗后发生寻常型天疱疮, objectType=article, longId=294843, objectId=dbdb29484362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbdb29484362, replyNumber=0, likeNumber=37, createdTime=2022-03-13, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbdb29484362, moduleTitle=JEADV：89岁患者接种SARS-CoV-19BNT162b2疫苗后发生寻常型天疱疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbdb29484362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938065, encodeId=bdd819380652f, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性, objectType=article, longId=292961, objectId=bfce29296133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfce29296133, replyNumber=0, likeNumber=55, createdTime=2022-04-06, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfce29296133, moduleTitle=JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfce29296133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938069, encodeId=2b531938069e9, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Ann Rheum Dis：风湿病和肌肉骨骼疾病患者接种SARS-CoV-2疫苗的安全性如何？, objectType=article, longId=293614, objectId=d3f2293614da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3f2293614da, replyNumber=0, likeNumber=54, createdTime=2022-06-14, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3f2293614da, moduleTitle=Ann Rheum Dis：风湿病和肌肉骨骼疾病患者接种SARS-CoV-2疫苗的安全性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3f2293614da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938096, encodeId=cf321938096f9, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=J Autoimmun：接种SARS-CoV-2疫苗后引发的弥漫性-皮肤型系统性硬化症, objectType=article, longId=301404, objectId=41c3301404b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41c3301404b9, replyNumber=0, likeNumber=48, createdTime=2022-05-24, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41c3301404b9, moduleTitle=J Autoimmun：接种SARS-CoV-2疫苗后引发的弥漫性-皮肤型系统性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41c3301404b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SARS-CoV

2020-05-29

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

BioScience Trends：杨文明教授团队发现疏风解毒胶囊对SARS-CoV-2奥密克戎感染轻度患者有效

2023-03-03

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

ARD：在巴西大量自身免疫性风湿病患者中接种第三剂同源灭活SARS-CoV-2疫苗后免疫原性增加

2022-08-09

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Geroscience：SARS-CoV-2的持续病毒RNA脱落与住院COVID-19患者的谵妄发生率和6个月死亡率相关

2023-01-09

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JAMA:妊娠期接种SARS-CoV-2 疫苗安全无虞

2022-08-03

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

ARD：已患有风湿病和肌肉骨骼疾病的儿童和青少年感染 SARS-CoV-2 的结果

2022-12-30

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Lancet Rheumatology：自身免疫性风湿病患者的混合免疫（感染+疫苗）与疫苗诱导的针对SARS-CoV-2 的免疫比较

2022-12-30

hb2008ye (审核中...)

前往app查看评论内容

#SARS-CoV#

JNNP:与SARS-CoV-2感染相关的急性缺血性中风研究

2022-09-01

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nat Commun：中和先前非 Omicron 感染的 Omicron SARS-CoV-2

2022-06-06

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

MOL THER| 妙！科学家发现咀嚼含有ACE2蛋白的口香糖或减少SARS-CoV-2传播

2022-08-08

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

J Hematol Oncol：癌症患者接种SARS-COV2疫苗后的血清学反应

2022-11-20

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

MMWR：在B.1.617.2(Delta)和B.1.1.529(Omicron)变异优势时期住院的经实验室确认的SARS-CoV-2感染成人的临床特征和转归

2022-07-12

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

AJH：接受鲁索替尼治疗的骨髓增殖性肿瘤患者对首次 SARS-CoV-2 疫苗接种的反应受损

2022-09-19

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nat Med：孕妇COVID-19疫苗接种与SARS-CoV-2感染

2022-09-28

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Crit Care：SARS-CoV-2相关性中重度低氧性呼吸衰竭患者早期长时间俯卧位是否能改善无创呼吸机治疗的临床结果

2022-11-09

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Bioorg Med Chem：羟氯喹抗SARS-CoV-2病毒，再现曙光！

2022-11-28

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JNNP:在接受芬戈莫德治疗的多发性硬化症患者中，SARS-CoV-2 mRNA疫苗接种未能引发体液和细胞免疫反应

2023-05-26

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JEADV：89岁患者接种SARS-CoV-19BNT162b2疫苗后发生寻常型天疱疮

2022-03-13

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性

2022-04-06

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Ann Rheum Dis：风湿病和肌肉骨骼疾病患者接种SARS-CoV-2疫苗的安全性如何？

2022-06-14

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

J Autoimmun：接种SARS-CoV-2疫苗后引发的弥漫性-皮肤型系统性硬化症

2022-05-24

科室
- - 订阅+
  - 更多科室
工具
服务